BACKGROUND: Acute myocardial infarction (AMI) is a major cardiovascular complication of noncardiac surgery. We aimed to evaluate the frequency, causes, and outcomes of 30-day hospital readmission after perioperative AMI.
P
erioperative acute myocardial infarction (AMI) is a potentially devastating cardiovascular complication for millions of patients undergoing major noncardiac surgery each year. [1] [2] [3] [4] Among patients at increased risk for cardiovascular complications, perioperative AMI can occur in up to 5% of major noncardiac inpatient surgeries and is strongly associated with morbidity, longer lengths of stay, and in-hospital mortality. [5] [6] [7] Outcomes of patients with perioperative AMI after hospital discharge are less certain. Hospital readmission is a frequently cited quality metric after noncardiac surgery and in patients with cardiovascular disease, with significant implications to costs of care, patient quality of life, and major adverse outcomes. 8 The objective of the present study was to evaluate rates of hospital readmission in patients with and without perioperative AMI and to identify causes of rehospitalization using a large administrative database of US hospital admissions.
METHODS

Study Population
Adults ≥18 years of age undergoing major noncardiac surgery in 2014 were identified from the US Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project's (HCUP) Nationwide Readmission Database (NRD). The 2014 NRD is a national administrative database of discharge-level data from community hospitals in 22 states that collectively represent 51.2% of the US population and 49.3% of all US hospitalizations. 9 Patients undergoing major noncardiac surgery were included in the analysis if they had a principal International Classification of Diseases, Ninth Revision (ICD-9) procedure code for a major therapeutic operating room procedure (HCUP procedure class 4) during the index hospital admission as previously described. 5 Principal Clinical Classifications Software procedure codes, Agency for Healthcare Research and Quality-defined groups of related ICD-9 procedure codes, were used to identify cases by surgical subtype. Patients who underwent cardiac procedures, cardiac surgery and transplantation, bone marrow transplantation, ophthalmologic surgery, radiation therapy, dental surgery, and nonoperating room procedures were excluded from the analysis. Major noncardiac surgery Clinical Classifications Software procedure codes were clustered into 9 major surgical subtypes: general, genitourinary, neurosurgery, orthopedic, otolaryngology, skin and breast, thoracic, vascular surgery, and other noncardiac surgeries not classified elsewhere. Patients with perioperative AMI were identified using ICD-9 diagnosis codes for acute ST-segment elevation MI (STEMI) (410.01-410.61, 410.81, and 410.91) and non-STEMI (NSTEMI) (410.71).
The primary study outcome was 30-day hospital readmission. Patients who underwent major noncardiac surgery and were discharged in December 2014 (n=354 953) were excluded from the analysis because of incomplete follow-up data from the calendar-year files. For patients with >1 perioperative AMI, only the first surgical hospitalization with perioperative AMI was included in the final analysis. In the cohort of patients without any perioperative AMI who underwent multiple surgeries, only the first hospitalization for surgery in the calendar year was included in the final analysis.
Patient Characteristics, Hospital Readmission, and Outcomes
We included patient demographics and relevant comorbidities during the index hospitalization as defined by ICD-9 diagnosis codes. Thirty-day hospital readmissions were determined based on methodology outlined by HCUP. 10 Among patients with multiple readmissions within 30 days, only the first readmission was included for analysis.
Primary ICD-9 diagnosis codes were used to determine the indication for hospital readmission and were clustered into the following clinically relevant categories: bleeding, cardiovascular disorders, endocrine disorders, gastrointestinal disorders, infectious complications, malignancy, metabolic disorders, musculoskeletal disorders, neurological disorders, peripheral vascular disease, pulmonary disorders, renal disorders, wound or device complications, and other complications not classified elsewhere. Hospital length of stay, total costs, and in-hospital mortality were also evaluated. Healthcare costs were derived according to HCUP guidance by multiplying the total charge for each admission by the cost-to-charge ratios reported for each hospital.
Statistical Analysis
Continuous variables were reported as mean±standard deviation and compared using Student's t test. Categorical variables were reported as percentages and compared by
Clinical Perspective
What Is New?
• Perioperative acute myocardial infarction (AMI) after noncardiac surgery is associated with high inhospital mortality and a 19% risk of 30-day hospital readmission among survivors.
• The majority of hospitalizations after perioperative AMI are because of infectious, cardiovascular, or bleeding complications.
• Recurrent AMI occurs in 11% of patients rehospitalized after perioperative AMI.
• At 6 months after perioperative AMI, 36.2% of patients were rehospitalized, and the overall risk of in-hospital death (during the index admission or first rehospitalization) was 17.6%.
What Are the Clinical Implications?
• AMI is a major cardiovascular complication of noncardiac surgery.
• Hospital readmissions and mortality among patients with perioperative AMI pose a significant burden to the healthcare system. • Strategies to improve outcomes of surgical patients early after perioperative AMI are warranted.
ORIGINAL RESEARCH ARTICLE
χ-square tests. Multivariable logistic regression models were generated to estimate odds ratios (ORs) adjusted for patient demographics, cardiovascular risk factors, and comorbidities. Models included age, sex, race/ethnicity, obesity, tobacco use, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, end stage renal disease, coronary artery disease, prior revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, peripheral arterial disease, congestive heart failure, valvular heart disease, prior venous thromboembolism, chronic lung disease, malignancy, anemia, alcohol abuse, elective/urgent hospitalization, surgery type, and year of hospitalization as covariates for adjustment. A sensitivity analysis of patients with perioperative AMI who were discharged from the index hospitalization in January through June 2014 was also performed to determine 180-day hospital readmission. To exclude cases in which AMI may have preceded noncardiac surgery, sensitivity analyses were performed after excluding patients who were urgently or emergently hospitalized for their index surgery and in a cohort of patients who underwent the index noncardiac surgery within the first 48 hours of hospital presentation.
Sampling weights were applied to determine national incidence estimates according to HCUP guidance. 11 Statistical analyses were performed using SPSS 20 (IBM SPSS Statistics). Statistical tests are 2-sided, and P values <0.05 were considered to be statistically significant. The NRD is a publicly available, deidentified dataset, and the study was exempt from institutional board review. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
RESULTS
Study Population
Among the 29 699 157 adult hospitalizations recorded in the 2014 NRD, there were 4 162 310 hospitalizations for major noncardiac surgery; after excluding discharges in December 2014, 3 807 357 surgical hospitalizations met study inclusion criteria. Perioperative AMI occurred in 8100 hospitalizations for surgery (0.2%), with 8085 unique patients identified. Among 3 799 257 surgical hospitalizations without AMI, 3 653 144 unique patients were identified. Baseline characteristics of patients with and without perioperative AMI are shown in Table 1 . Patients with AMI were older, more likely to be male, and had a greater burden of conventional risk factors for coronary artery disease. Among patients with perioperative AMI, STEMI occurred in 1501 (18.6%) and NSTEMI in 6584 (81.4%). Coronary revascularization was performed in 15.8% of patients with perioperative AMI (12.5% of NSTEMI and 30.4% of STEMI). During the index hospitalization, mortality was higher in patients undergoing noncardiac surgery with perioperative AMI compared with patients without perioperative AMI (14.0% versus 0.3%, P<0.001). Among patients with perioperative AMI, mortality was higher in patients with STEMI compared with NSTE- 
Incidence, Causes, and Outcomes of 30-Day Hospital Readmission
The overall incidence of 30-day hospital readmission among survivors of perioperative AMI was 19.1% (1324 readmissions) compared with 6.5% (237 804 readmissions) among patients undergoing noncardiac surgery without perioperative AMI (P<0.001; adjusted OR, 1.39; 95% confidence interval, 1.31-1.48). Similar findings were observed after excluding patients who were urgently or emergently hospitalized for their index surgery or underwent the index noncardiac surgery within the first 48 hours of hospital presentation ( Table  I in the online-only Data Supplement). No difference in the frequency of hospital readmission was observed between survivors of perioperative STEMI and NSTEMI (20.0% versus 18.9%, P=0.42). Among patients readmitted within 30 days, the median time to hospitalization after perioperative AMI was 15 days (IQR, 9-22 days) compared with 10 days (IQR, 5-18 days) among surgical patients without AMI during the index hospitalization (P<0.001). Recurrent AMI during readmission were more common among patients with a prior perioperative AMI compared with those without recent perioperative AMI (10.9% versus 1.5%, P<0.001). Patients with recent perioperative AMI were less likely to undergo a second major noncardiac surgery during hospital readmission than patients without perioperative AMI (6.7% versus 14.2%, P<0.001).
The most common indications for 30-day hospital readmission were management of infectious complications (30.0%), cardiovascular complications (25.3%), and bleeding complications (10.4%) among patients with perioperative AMI during the index surgical admission, and infectious complications (30.6%), gastrointestinal complications (12.0%), and cardiovascular complications (8.2%) among patients without perioperative AMI ( Table 2 ). The most common primary ICD-9 diagnoses for 30-day hospital readmission in patients with recent perioperative AMI were septicemia in 11.2%, acute NSTEMI in 5.1%, postoperative infection in 4.1%, acute kidney failure in 2.8%, acute on chronic systolic heart failure in 2.7%, acute on chronic diastolic heart failure in 2.6%, and pneumonia in 2.5% (see Table II ORIGINAL RESEARCH ARTICLE for infectious complications, 11.1% of admissions for bleeding complications, and 9.2% of admissions for infectious complications. Among patients without perioperative AMI during their index surgical admission, the most common primary ICD-9 diagnoses for 30-day hospital readmission were postoperative infection in 9%, septicemia in 4.6%, digestive system complications in 2.9%, and acute kidney failure in 2% of patients without perioperative AMI.
Median length of stay during readmission was 5 days (IQR, 3-8) among patients with perioperative AMI compared with 4 days (IQR, 2-7) among patients without perioperative AMI (P<0.001). The median cost of hospital readmission within 30 days after perioperative AMI was $9893 (IQR, $5712-$17 398) compared with $8083 (IQR, $4659-$14 834) for readmissions among patients without recent perioperative AMI (P<0.001). Among patients who were readmitted within 30 days, 11.3% (150 patients) with a recent perioperative AMI died in-hospital during their first hospital readmission compared with 2.5% (5867 patients) without recent perioperative AMI (P<0.001). Among the 150 patients with perioperative AMI who died during 30-day hospital readmission, infectious complications (51.6%), cardiovascular complications (17.2%), and pulmonary complications (9.6%) were the most common indications for hospitalization. Overall, 30-day in-hospital 
Surgery-Specific Risks Associated With Perioperative AMI
Risks of death and 30-day readmission after perioperative AMI varied by the subtype of noncardiac surgery performed during the index hospitalization (Figure) . Risk of death during the index admission was highest among patients with AMI, complicating thoracic surgery (28.4%), general surgery (20.3%), vascular surgery (15.3%), and neurosurgery (12.5%). Among patients with perioperative AMI who survived to discharge during the index hospitalization, 30-day readmission was common among all surgical subtypes (Figure) . Thirty-day in-hospital mortality (death during the index admission or during first hospital readmission within 30 days) was highest among patients with AMI undergoing thoracic surgery (30.9%), general surgery (22.4%), vascular surgery (17.2%), and neurosurgery (13.9%).
180-Day Follow-Up
In a sensitivity analysis of patients with perioperative AMI who were discharged from the index surgical hospitalization from January through June 2014 with 180-day follow-up data available (n=4305), 637 patients died in-hospital (14.8%), and 1557 survivors (42.4%) were readmitted within 6 months of follow-up. Of those readmitted, an additional 122 patients (7.8%) died during the hospital readmission. The 180-day inhospital mortality (death during the index admission or during first hospital readmission within 180 days) was 17.6%.
DISCUSSION
In a large national readmission database of adults admitted for major noncardiac surgery, nearly 1/3 of patients identified as having perioperative AMI died during the index hospitalization or were readmitted within 30 days of discharge, and half of these patients died or were readmitted by 6 months. Among the 19% of patients who survived to discharge and had a hospital readmission within 30 days, infec- tious, cardiovascular, and bleeding complications were the most common primary diagnoses associated with hospital readmission. This report is the first to explore 30-day hospital readmissions in patients with perioperative AMI after noncardiac surgery in the United States. Despite recent declines in the incidence of perioperative AMI in high-risk patients, cardiovascular events continue to be a major source of morbidity and mortality after noncardiac surgery. 5 Analyses of the large American College of Surgeons National Surgical Quality Improvement Program previously identified associations between in-hospital cardiovascular complications and unplanned readmissions postdischarge, even when controlling for baseline patient risk and surgical complexity. 8, 12 However, these analyses did not provide data on hospital readmission among patients with perioperative MI. In the present study, survivors of perioperative AMI had significantly higher 30-day rates of readmission than surgical patients without perioperative AMI after adjustment for demographics, surgical subtype, and cardiovascular risk factors. Nearly 1 in every 3 patients with perioperative AMI died or required hospital readmission within 30 days, with a higher risk observed in patients with perioperative STEMI compared with NSTEMI. Among patients who survived the surgical hospitalization and were readmitted within 30 days, 1 in every 4 presented with another cardiovascular complication, and 11% of these patients had a recurrent AMI. In addition to recurrent cardiovascular complications associated with AMI, prolonged length of stay during the index hospitalization after AMI can lead to other hospital-acquired complications of surgery, including hospital-acquired infections, venous thromboembolism, and physical deconditioning. These factors may exacerbate adverse outcomes in this population and substantially increase risks of hospital readmission.
Reductions in readmissions after AMI and surgery have become major goals for both payers and providers in the United States. In 2012, the US Centers for Medicare and Medicaid launched the Hospital Readmission Reduction Program, a program to reduce payments to hospitals with excess hospital readmissions. The Hospital Readmission Reduction Program has already demonstrated beneficial changes in clinical practice, with declines in readmissions in medical and surgical target and nontarget conditions at hospitals subjected to penalties. 13, 14 Despite these early successes, hospital readmissions in patients with perioperative AMI in the setting of noncardiac surgery continue to burden the healthcare system, and additional efforts to improve outcomes in this high-risk population are necessary.
Unfortunately, the optimal prevention and management of patients with perioperative AMI remain uncertain, and medical interventions and systems of care to reduce death and hospital readmissions in this population have not been established. 15 Complicating matters, perioperative AMI can represent either type 1 MI (AMI because of unstable coronary artery disease and plaque rupture) or type 2 MI (AMI because of a mismatch in myocardial oxygen supply and demand that occurs in the absence of unstable coronary artery disease). Although both AMI subtypes are associated with adverse outcomes, optimal treatment may differ. 16 Current clinical practice guidelines recommend management of perioperative AMI according to guidelines for the general population but with "modifications based on the severity of NSTE-ACS and the limitations imposed by the noncardiac surgical procedure." 17 Increased prescribing of guideline-directed medical therapy for atherosclerotic cardiovascular disease and appropriate referral for invasive management of AMI may further reduce cardiovascular risks in this complex patient population.
Study Limitations
This analysis has a few limitations. First, NRD data are derived from diagnosis codes recorded in state administrative databases and are subject to errors in coding and reporting bias. Large numbers of relatively low-risk patients may contribute to the lower incidence of perioperative AMI observed in the NRD compared with other studies that restricted analyses to the highest-risk subgroups. The diagnosis of perioperative AMI may be underreported or missed entirely. Many perioperative AMIs are clinically silent and may not be recognized by treating physicians without routine ECG and biomarker screening. 18 In prior analyses, ≤2/3 of perioperative AMI can occur without overt ischemic symptoms. 19 Even in the absence of overt AMI, silent perioperative elevations in troponin are associated with increased postoperative 30-day and long-term mortality. [18] [19] [20] Providers in certain surgical subspecialties may be less inclined to measure serum biomarkers in the postoperative period, and rates of postoperative AMI diagnosis may vary based on the frequency of cardiac biomarker measurement. Because results of perioperative laboratory testing were not available in this administrative dataset, the frequency of cardiac biomarker measurement in this cohort is unknown. As a consequence, readmission rates are uncertain for patients who developed myocardial injury after noncardiac surgery without an overt AMI. Furthermore, contemporary clinical practice guidelines recommend against routine postoperative troponin screening after noncardiac surgery, and therefore silent AMIs are likely to be routinely missed in clinical practice. 15 Still our findings are consistent with highrisk subsets of patients enrolled in prior prospective ORIGINAL RESEARCH ARTICLE studies. Among patients who developed myocardial injury after noncardiac surgery with an ischemic feature consistent with AMI in the VISION study (Vascular Events in Noncardiac Surgery Patients Cohort Evaluations), 30-day mortality rate was 13.5%. [19] [20] [21] In this analysis, in-hospital mortality was 14%. Thus, our findings are consistent with the high-risk subset of patients enrolled in VISION and reflect the outcomes of a large, real-world, high-risk population of patients diagnosed with perioperative AMI.
Second, discrete clinical data, including the results of diagnostic coronary angiography and measurement of left ventricular function, were not captured in this administrative dataset. Differentiation of type 1 and type 2 AMI subtypes was not possible because of limitations of ICD-9 coding. However, only 16% of patients with AMI underwent coronary revascularization in this cohort, suggesting that many cases may have been because of type 2 AMI. Third, in-hospital or discharge medications were not available for review and could not be determined. Fourth, the sequence of noncardiac surgery preceding AMI cannot be confirmed in this administrative database. However, noncardiac surgery is contraindicated early after AMI, and patients admitted to the hospital for AMI would be unlikely to undergo major noncardiac surgery during the same hospital admission. Fifth, although inhospital deaths within 30 days were identified from this in-hospital dataset, out-of-hospital mortality after perioperative AMI could not be determined. Finally, because of limitations of calendar-year datasets, long-term rates of hospital readmission could not be determined within the full cohort. Although the risk of readmission after AMI is highest immediately after hospital discharge, 22 prior studies suggest that perioperative myocardial injury and AMI are associated with long-term mortality in addition to the short-term risks of death and rehospitalization. 23 
CONCLUSIONS
Among patients undergoing noncardiac surgery with a perioperative MI, ≈1 in 7 patients died, and 1 in 5 were readmitted within the first 30 days after discharge. Two thirds of hospital readmissions occurred because of infectious, cardiovascular, or bleeding complications. By 6 months, 50% of patients with a perioperative MI died or were rehospitalized at least once. Strategies to improve outcomes of surgical patients early after perioperative AMI are warranted.
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